Karyopharm Therapeutics Inc  (KPTI) - NASDAQGS

  Revenue / EPS Summary *  
 
 Fiscal Quarter 2019
(Fiscal Year)
2018
(Fiscal Year)
2017
(Fiscal Year)
March      
   Revenue $155,000 $10,000(t) $68,000
   EPS -1.09 (3/31/2019) -0.78 (3/31/2018) -0.71 (3/31/2017)
   Dividends N/A N/A N/A
June      
   Revenue $9,493(t) $19,891(t) $3,000
   EPS -0.71 (6/30/2019) -0.58 (6/30/2018) -0.64 (6/30/2017)
   Dividends N/A N/A N/A
September      
   Revenue   $239,000 $0
   EPS   -0.81 (9/30/2018) -0.65 (9/30/2017)
   Dividends   N/A N/A
December  (FYE)      
   Revenue   $206,000 $1,534(t)
   EPS   -0.97 (12/31/2018) -0.81 (12/31/2017)
   Dividends   N/A N/A
Totals      
   Revenue $9,648(t) $30,336(t) $1,605(t)
   EPS -1.8 -3.14 -2.81
   Dividends N/A N/A N/A
   Previous 3 Years
 
 
©2019, EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.